Abstract
This review gives a survey on the use and applications of technetium-94m (94mTc) as a non-conventional positron emission tomography (PET) radionuclide for molecular imaging. The first part of this review describes the production and processing of 94mTc. The second part covers basic concepts of technetium coordination chemistry with a special focus on the synthesis of 94mTc-labeled compounds for molecular imaging purposes. The review concludes with a summary and an outlook on the prospects of using 94mTc in the field of PET chemistry and molecular imaging.
Keywords: Technetium-94m, positron emission tomography, radiopharmaceuticals, molecular imaging, 94mTc Production, Thermochromatographic Separation, Solvent Extraction, PET Imaging, COORDINATION CHEMISTRY
Current Radiopharmaceuticals
Title: Radiotracers Based on Technetium-94m
Volume: 4 Issue: 2
Author(s): Katherine Gagnon, Steve McQuarrie, Doug Abrams, Alexander J. McEwan and Frank Wuest
Affiliation:
Keywords: Technetium-94m, positron emission tomography, radiopharmaceuticals, molecular imaging, 94mTc Production, Thermochromatographic Separation, Solvent Extraction, PET Imaging, COORDINATION CHEMISTRY
Abstract: This review gives a survey on the use and applications of technetium-94m (94mTc) as a non-conventional positron emission tomography (PET) radionuclide for molecular imaging. The first part of this review describes the production and processing of 94mTc. The second part covers basic concepts of technetium coordination chemistry with a special focus on the synthesis of 94mTc-labeled compounds for molecular imaging purposes. The review concludes with a summary and an outlook on the prospects of using 94mTc in the field of PET chemistry and molecular imaging.
Export Options
About this article
Cite this article as:
Gagnon Katherine, McQuarrie Steve, Abrams Doug, J. McEwan Alexander and Wuest Frank, Radiotracers Based on Technetium-94m, Current Radiopharmaceuticals 2011; 4 (2) . https://dx.doi.org/10.2174/1874471011104020090
DOI https://dx.doi.org/10.2174/1874471011104020090 |
Print ISSN 1874-4710 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4729 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Treatment of Nasopharyngeal Carcinoma: Therapeutic Management and Future View of Epstein-Barr Virus-Targeting Treatment
Current Cancer Therapy Reviews Second Line Treatments in Advanced Platinum-Resistant Non Small Cell Lung Cancer. A Critical Review of Literature
Reviews on Recent Clinical Trials The Transcription Factor ETS-1: Its Role in Tumour Development and Strategies for its Inhibition
Mini-Reviews in Medicinal Chemistry Diterpenoids from Liverworts and their Biological Activities
Current Organic Chemistry Antiangiogenesis in Myelodysplastic Syndrome
Current Cancer Drug Targets Obesity Modulation - The Role in Carcinogenesis
Anti-Cancer Agents in Medicinal Chemistry The Coronin Family and Human Disease
Current Protein & Peptide Science Chemokines as Therapeutic Targets in Non-Small Cell Lung Cancer
Current Medicinal Chemistry - Anti-Cancer Agents Recent Updates on the Therapeutic Potential of HER2 Tyrosine Kinase Inhibitors for the Treatment of Breast Cancer
Current Cancer Drug Targets Long Noncoding RNA MALAT1: Insights into its Biogenesis and Implications in Human Disease
Current Pharmaceutical Design Segmentation and Classification of Lung Cancer: A Review
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Current and Emerging Therapy for Malignant Pleural Mesothelioma: Focus on CD26/Dipeptidyl Peptidase IV as a Therapeutic Target
Current Cancer Therapy Reviews Induced Fit Docking and Automated QSAR Studies Reveal the ER-α Inhibitory Activity of <i>Cannabis sativa</i> in Breast Cancer
Recent Patents on Anti-Cancer Drug Discovery Biological Activities, Mechanisms of Action and Biomedical Prospect of the Antitumor Ether Phospholipid ET-18-OCH3 (Edelfosine), A Proapoptotic Agent in Tumor Cells
Current Drug Metabolism Pulmonary Manifestations of Rheumatoid Arthritis, Psoriatic Arthritis and Peripheral Spondyloarthritis: Prevalence, Diagnostic Approach and Treatment Options
Current Rheumatology Reviews Inhibiting Cyclin-Dependent Kinase / Cyclin Activity for the Treatment of Cancer and Cardiovascular Disease
Current Pharmaceutical Biotechnology Recent Research Trends on Bismuth Compounds in Cancer Chemoand Radiotherapy
Current Medicinal Chemistry Novel Purine Nucleoside Analogues for Hematological Malignancies
Recent Patents on Anti-Cancer Drug Discovery Second-line Treatment of Advanced Non-small Cell Lung Cancer Non-oncogene Addicted: New Treatment Algorithm in the Era of Novel Immunotherapy
Current Clinical Pharmacology Synthesis, DNA Binding Ability and Anticancer Activity of 2-heteroaryl Substituted Benzimidazoles Linked Pyrrolo[2,1-c][1,4]benzodiazepine Conjugates
Medicinal Chemistry